Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Novo Nordisk A/S

    World Rank (Jan-05-2024)
    16
    Market Cap (Jan-05-2024)
    459.394 Billion USD
    World Rank (Jul-30-2023)
    24
    Market Cap (Jul-30-2023)
    356.920 Billion USD
    World Rank (Dec-25-2022)
    27
    Market Cap (Dec-25-2022)
    301.520 Billion USD
    World Rank (Jan-07-2022)
    50
    Market Cap (Jan-07-2022)
    231.35 Billion USD
    Annual Revenue in USD
    33,748 Million USD
    Annual Operating Income in USD
    14,904 Million USD
    Annual Net Income in USD
    12,159 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquarters is in Denmark.

    Novo Nordisk employs approximately 55,185 employees in 79 countries as on 2022 and markets its products in more than 170 countries.

    Facts About Company

    For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

    For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

  2. Amgen

    World Rank (Jan-05-2024)
    73
    Market Cap (Jan-05-2024)
    162.250 Billion USD
    World Rank (Jul-30-2023)
    105
    Market Cap (Jul-30-2023)
    126.300 Billion USD
    World Rank (Dec-25-2022)
    80
    Market Cap (Dec-25-2022)
    140.820 Billion USD
    World Rank (Jan-07-2022)
    113
    Market Cap (Jan-07-2022)
    128.03 Billion USD
    Annual Revenue in USD
    28,190 Million USD
    Annual Operating Income in USD
    7,897 Million USD
    Annual Net Income in USD
    6,717 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Company Profile

    Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

    Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

    Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

    Facts About Company

    As on 2022, Amgen has 25,200 employees.

    Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

    Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

    Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

    Split of Annual Revenue by business segment for period ending Dec-2021:

  3. Gilead Sciences

    World Rank (Jan-05-2024)
    133
    Market Cap (Jan-05-2024)
    105.265 Billion USD
    World Rank (Jul-30-2023)
    154
    Market Cap (Jul-30-2023)
    95.871 Billion USD
    World Rank (Dec-25-2022)
    120
    Market Cap (Dec-25-2022)
    106.300 Billion USD
    World Rank (Jan-07-2022)
    180
    Market Cap (Jan-07-2022)
    89.39 Billion USD
    Annual Revenue in USD
    27,116 Million USD
    Annual Operating Income in USD
    8,810 Million USD
    Annual Net Income in USD
    5,665 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

    As on 2022, GILEAD SCIENCES INC has 17,000 employees.

    GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

    GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

  4. Moderna

    World Rank (Jan-05-2024)
    436
    Market Cap (Jan-05-2024)
    41.430 Billion USD
    World Rank (Jul-30-2023)
    397
    Market Cap (Jul-30-2023)
    45.234 Billion USD
    World Rank (Dec-25-2022)
    174
    Market Cap (Dec-25-2022)
    76.483 Billion USD
    World Rank (Jan-07-2022)
    188
    Market Cap (Jan-07-2022)
    86.71 Billion USD
    Annual Revenue in USD
    18,870 Million USD
    Annual Operating Income in USD
    9,420 Million USD
    Annual Net Income in USD
    8,360 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Moderna is Biotechnology sector company with headquarters is in Massachusetts, USA. It has done good work on Covid-19 vaccine.

    As on 2022, Moderna has 3,900 employees.

    Moderna annual revenue generated for period ending Dec-2022 was 18.87 billion USD.

    Moderna annual net income generated for period ending Dec-2022 was 8.36 billion USD.

    Moderna annual revenue generated for period ending Dec-2021 was 16,471 million USD.

  5. Biogen

    World Rank (Jan-05-2024)
    473
    Market Cap (Jan-05-2024)
    38.171 Billion USD
    World Rank (Jul-30-2023)
    470
    Market Cap (Jul-30-2023)
    38.390 Billion USD
    World Rank (Dec-25-2022)
    405
    Market Cap (Dec-25-2022)
    40.199 Billion USD
    World Rank (Jan-07-2022)
    609
    Market Cap (Jan-07-2022)
    34.17 Billion USD
    Annual Revenue in USD
    10,173 Million USD
    Annual Operating Income in USD
    2,901 Million USD
    Annual Net Income in USD
    3,046 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Biogen INC is USA based Bio-Technology Company and they are pioneers in neuroscience medical science. Headquarters is in Massachusetts, USA.

  6. Seagen

    World Rank (Jan-05-2024)
    515
    World Rank (Jul-30-2023)
    515
    Market Cap (Jul-30-2023)
    36.021 Billion USD
    World Rank (Dec-25-2022)
    714
    Market Cap (Dec-25-2022)
    23.583 Billion USD
    World Rank (Jan-07-2022)
    804
    Market Cap (Jan-07-2022)
    26.28 Billion USD
    Annual Revenue in USD
    1,962 Million USD
    Annual Operating Income in USD
    -612 Million USD
    Annual Net Income in USD
    -610 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    SEAGEN is Biotechnology company with headquarters is in Washington, USA.

    Pfizer acquired Seagen for 43 billion USD in 2023. Seagen manufactures Cancer drugs.

    As on 2022, SEAGEN has 3,256 employees.

    SEAGEN annual revenue generated for period ending Dec-2022 was 1,962 million USD.

    SEAGEN annual net loss generated for period ending Dec-2022 was -610 (Loss) million USD.

  7. BioNTech SE

    World Rank (Jan-05-2024)
    686
    Market Cap (Jan-05-2024)
    26.909 Billion USD
    World Rank (Jul-30-2023)
    725
    Market Cap (Jul-30-2023)
    25.887 Billion USD
    World Rank (Dec-25-2022)
    380
    Market Cap (Dec-25-2022)
    42.705 Billion USD
    World Rank (Jan-07-2022)
    369
    Market Cap (Jan-07-2022)
    51.38 Billion USD
    Annual Revenue in USD
    19,085 Million USD
    Annual Operating Income in USD
    13,939 Million USD
    Annual Net Income in USD
    10,402 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    BIONTECH SE is biotechnology company with headquarters is in Germany.

  8. Argenx SE

    World Rank (Jan-05-2024)
    802
    Market Cap (Jan-05-2024)
    22.967 Billion USD
    World Rank (Jul-30-2023)
    621
    Market Cap (Jul-30-2023)
    30.537 Billion USD
    World Rank (Dec-25-2022)
    799
    Market Cap (Dec-25-2022)
    20.875 Billion USD
    World Rank (Jan-07-2022)
    1,257
    Market Cap (Jan-07-2022)
    16.13 Billion USD
    Annual Revenue in USD
    410 Million USD
    Annual Operating Income in USD
    -719 Million USD
    Annual Net Income in USD
    -709 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Biopharmaceutical company with headquarters is in Netherlands.

  9. Neurocrine Biosciences

    World Rank (Jan-05-2024)
    1,326
    Market Cap (Jan-05-2024)
    13.124 Billion USD
    World Rank (Jul-30-2023)
    1,672
    Market Cap (Jul-30-2023)
    10.026 Billion USD
    World Rank (Dec-25-2022)
    1,362
    Market Cap (Dec-25-2022)
    11.566 Billion USD
    World Rank (Jan-07-2022)
    2,475
    Market Cap (Jan-07-2022)
    7.15 Billion USD
    Annual Revenue in USD
    1,488 Million USD
    Annual Operating Income in USD
    249 Million USD
    Annual Net Income in USD
    154 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Neurocrine Biosciences is a Neuroscience Focused and Biopharmaceutical company. It is discovering and developing life-changing treatments for people with serious, challenging, under addressed neurological, endocrine and psychiatric disorders. The headquarters is in USA.

  10. Bio-Techne Corporation

    World Rank (Jan-05-2024)
    1,474
    Market Cap (Jan-05-2024)
    11.453 Billion USD
    World Rank (Jul-30-2023)
    1,331
    Market Cap (Jul-30-2023)
    13.192 Billion USD
    World Rank (Dec-25-2022)
    1,229
    Market Cap (Dec-25-2022)
    12.986 Billion USD
    World Rank (Jan-07-2022)
    1,244
    Market Cap (Jan-07-2022)
    16.32 Billion USD
    Annual Revenue in USD
    1,136 Million USD
    Annual Operating Income in USD
    298 Million USD
    Annual Net Income in USD
    285 Million USD
    Annual Results for Period Ending
    Jun-2023 ending period
    Headquarters Country
    Stock Category
    Company Profile

    BIO-TECHNE CORPORATION is Biotechnology company with headquarters is in Minnesota, USA. It develops, manufactures and sells instruments, for and services research, diagnostics.

    BIO-TECHNE CORPORATION total number of employees in 2022 was 3,000, a 15.38% increase from 2021.

    BIO-TECHNE CORPORATION annual revenue generated for period ending Jun-2022 was 1,105 Billion USD.

    BIO-TECHNE CORPORATION annual net income generated for period ending Jun-2022 was 271 Billion USD.

Share

Ads